• Articles
    • Latest Articles
    • Commentaries
    • Deals
    • Distillery
    • Emerging Companies
    • Finance
    • Politics, Policy & Law
    • Product Development
    • Regulation
    • Targets & Mechanisms
    • Tools & Techniques
  • Current Editions
  • Search Archives
  • BCIQ
    • Company Profiles
    • Target Profiles
    • Product Profiles
  • Conferences
    • China Healthcare Summit
    • Bio€quity Europe
  • White Papers
  • Free Trial / Subscribe
  • Sign In
Biocentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Free Trial Information
  • Pipeline
  • Deals
  • Financings
  • Articles
BioCentury | Apr 25, 2020
Translation in Brief

Molecular Partners’ trifunctional COVID-19 therapeutic; plus F-star, Inscopix and Ocean Biomedical

...Partners AG F-star Biotechnology Ltd. Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274) Lymphocyte-activation gene 3 (LAG3) (CD223) COVID-19 Plasmodium falciparum glutamic acid-rich protein (P. falciparum GARP)...
Read More
Items per page:
10
1 - 1 of 1
Products & Solutions
  • Latest Articles
  • Products Overview
  • 简体中文
  • 日本語
  • 한국어
  • BCIQ
  • Conferences
  • White Papers
About Biocentury
  • Company Overview
  • Management
  • Editorial & Research
  • Scientific Advisory Board
Contact
  • Contact Us
  • Advertising & Sponsorship
  • Reprints & Permissions
  • Career Opportunities
  • Forgot Password
Privacy & Legal
  • User Agreement
  • Terms of Use
  • Privacy Policy
  • Your California Privacy Rights
  • Use of Images
  • Market data
  • Follow Us

    TwitterLinkedInRSS

© 2021 BioCentury Inc. All Rights Reserved.    Terms & Conditions | Privacy Policy

Previous page
Next page